Company registration number 09967270 (England and Wales)
CRANE MEDICAL LTD
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
CRANE MEDICAL LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 3
CRANE MEDICAL LTD
BALANCE SHEET
AS AT
31 MARCH 2025
31 March 2025
- 1 -
2025
2024
Notes
£
£
£
£
Current assets
Cash at bank and in hand
27,461
24,354
Creditors: amounts falling due within one year
3
(9,687)
(6,667)
Net current assets
17,774
17,687
Net assets
17,774
17,687
Capital and reserves
Called up share capital
4
5
5
Profit and loss reserves
17,769
17,682
Total equity
17,774
17,687

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

T he member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and signed by the director and authorised for issue on 2 October 2025
Dr J A Crane
Director
Company registration number 09967270 (England and Wales)
CRANE MEDICAL LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 2 -
1
Accounting policies
Company information

Crane Medical Ltd is a private company limited by shares incorporated in England and Wales. The registered office is Talville, Cardiff Road, Creigau, CF15 9NL.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes.

1.3
Financial instruments

Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.

1.4
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

CRANE MEDICAL LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 3 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
2
2
3
Creditors: amounts falling due within one year
2025
2024
£
£
Corporation tax
1,687
1,167
Other creditors
8,000
5,500
9,687
6,667
4
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary of £1 each
3
3
3
3
Ordinary A of £1 each
1
1
1
1
Ordinary B of £1 each
1
1
1
1
5
5
5
5
2025-03-31 2024-04-01 false false false CCH Software CCH Accounts Production 2025.100 No description of principal activity Dr J A Crane 09967270 2024-04-01 2025-03-31 09967270 2025-03-31 09967270 2024-03-31 09967270 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 09967270 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 09967270 core:CurrentFinancialInstruments 2025-03-31 09967270 core:CurrentFinancialInstruments 2024-03-31 09967270 core:ShareCapital 2025-03-31 09967270 core:ShareCapital 2024-03-31 09967270 core:RetainedEarningsAccumulatedLosses 2025-03-31 09967270 core:RetainedEarningsAccumulatedLosses 2024-03-31 09967270 core:ShareCapitalOrdinaryShareClass1 2025-03-31 09967270 core:ShareCapitalOrdinaryShareClass1 2024-03-31 09967270 core:ShareCapitalOrdinaryShareClass2 2025-03-31 09967270 core:ShareCapitalOrdinaryShareClass2 2024-03-31 09967270 core:ShareCapitalOrdinaryShareClass3 2025-03-31 09967270 core:ShareCapitalOrdinaryShareClass3 2024-03-31 09967270 core:ShareCapitalOrdinaryShares 2025-03-31 09967270 core:ShareCapitalOrdinaryShares 2024-03-31 09967270 bus:Director1 2024-04-01 2025-03-31 09967270 2023-04-01 2024-03-31 09967270 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 09967270 bus:OrdinaryShareClass2 2024-04-01 2025-03-31 09967270 bus:OrdinaryShareClass3 2024-04-01 2025-03-31 09967270 bus:OrdinaryShareClass1 2025-03-31 09967270 bus:OrdinaryShareClass1 2024-03-31 09967270 bus:OrdinaryShareClass2 2025-03-31 09967270 bus:OrdinaryShareClass2 2024-03-31 09967270 bus:OrdinaryShareClass3 2025-03-31 09967270 bus:OrdinaryShareClass3 2024-03-31 09967270 bus:AllOrdinaryShares 2025-03-31 09967270 bus:AllOrdinaryShares 2024-03-31 09967270 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 09967270 bus:FRS102 2024-04-01 2025-03-31 09967270 bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 09967270 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 09967270 bus:FullAccounts 2024-04-01 2025-03-31 xbrli:pure xbrli:shares iso4217:GBP